2021, Debt and Negotiation - Investment Banking Today

Medical Debt

Wall Street Mojo

JANUARY 14, 2024

What Is Medical Debt ? Medical Debt refers to a financial obligation incurred by an individual due to unpaid bills for medical services obtained from a healthcare provider. The debt may be owed directly to a healthcare provider or a third-party agent, such as a collection agency, that bought the debt.

Debt

Debt Medical Healthcare Insurance

How the Growth of Private Credit is Impacting Private Equity

OfficeHours

AUGUST 25, 2023

In particular, new guidelines from the FDIC and Federal Reserve (among other governmental agencies) made it more difficult for banks to underwrite financings that resulted in debt-to-EBITDA ratios in excess of 6.0x. This capital is released once investors buy the debt off the banks’ balance sheets.

Private Equity

Private Equity Equities Debt Finance

Earnouts: Bridging the Gap in Price Negotiation

IBG

AUGUST 21, 2023

A powerful tool in negotiating a business’s purchase price, an earnout can bridge the gap between the amount that a buyer is willing to pay and the seller is willing to accept. If the sale occurs in a high-interest-rate environment, an earnout can help narrow the gap created by debt coverage. You might be right, but we’re not so sure.

Negotiation

Negotiation Profitability Business Sale

Comprehensive Guide to M&A Due Diligence in Today’s Turbulent Economic Environment

Devensoft

JUNE 1, 2023

A recent report by EY states that M&A activity reached record levels in 2021, with a total deal value of $5.8 By following these guidelines, businesses can make informed decisions, negotiate favorable terms, and mitigate risks to maximize the value of their M&A transactions. trillion, up 72% from the previous year.

Economics

Economics M&A Management Financial Statement

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

JANUARY 25, 2023

Although 2022 saw a general decline in M&A activity in the life sciences industry compared to 2021’s frenetic pace (when deal volume was up 52% from 2020 ), life sciences deal flow in 2022 on balance remained strong despite the headwinds. Let’s dig in.

M&A

M&A Mergers and Acquisitions Pharmaceutical Collaboration

A Rollercoaster Ride for Software Markets

Intrepid Banker Insights

OCTOBER 17, 2022

We ended 2021 having survived another year of the pandemic, with equity markets at or near all-time highs, interest rates near historic lows, and technology M&A activity at record levels. Intrepid Investment Bankers A Rollercoaster Ride for Software Markets It has been a disconcerting journey through the first three quarters of 2022.

Valuation

Valuation M&A Capital Middle Market

Have Your Cake, and Closing Too: Invoking Prevention Doctrine, Delaware Chancery Court Grants Seller’s Request for Specific Performance in COVID-Related M&A Dispute

Cooley M&A

MAY 21, 2021

April 30, 2021) is 125 pages long, but she helpfully digests the holding in a single sentence on page 3: “ Chalking up a victory for deal certainty , this post-trial decision resolves all issues in favor of seller and orders the buyers to close on the purchase agreement.” Chancellor McCormick’s opinion in Snow Phipps Group, LLC, et al.

M&A

M&A Debt Private Equity Finance

2024 Insurance M&A Market Update: Robust But Complicated

Sica Fletcher

JUNE 20, 2024

This is even more interesting when we view the rate of return for these insurance agencies, which has actually dropped below the cost of acquiring debt for a transaction, creating a negative spread for the first time in M&A history. Deal Volume Has Lowered Deal volume has never quite recovered from the near-record numbers posted in 2021.

M&A

M&A Insurance Valuation Equities

Leaders in Trading 2023: Meet the nominees for… Outstanding Post-Trade Services Provider

The TRADE

OCTOBER 24, 2023

In January of this year, the exchange negotiated the early termination of its derivatives clearing agreement with LSEG clearing house LCH SA. In June 2022, Euronext and LCH RepoClear concurrently launched Value at Risk (VaR) methodologies across the respective debt markets they clear, across fixed income, equity and equity derivatives.

Trading

Trading Risk Management Equities Management

Schemes of Arrangement: Dodgy Plots or Effective Ways to Purchase UK Companies?

Cooley M&A

APRIL 26, 2022

A scheme of arrangement is the most common structure for acquiring a UK public company when the target’s board is supportive of the deal – accounting for 81% of announced public deals in 2021 (up from 69% in 2020 and 71% in 2019) – and also can be used for private company acquisitions.

Mergers and Acquisitions

Mergers and Acquisitions Shares Stock Acquisitions

Insurance Brokerage M&A Report, H2 2024

Sica Fletcher

JULY 23, 2024

Since H2 2022, industries across the board (including insurance) have seen declines in deal volume as prospective buyers have withheld their funds for more favorable conditions in which the cost of debt is not so high. This means that they often lack the specialized industry knowledge to effectively negotiate your deal.

M&A

M&A Insurance S&P Valuation

Diving Into Delaware’s Enforcement of Specific Performance in M&A Transactions

Cooley M&A

OCTOBER 8, 2024

the Chancery Court ordered specific performance and enforced a reasonable best efforts provision to require a buyer to secure debt financing and close the transaction, where all of the buyer’s closing conditions (other than the condition to complete buyer’s financing) had been satisfied. KCake Acquisition Inc. , Hill-Rom Inc. ,

M&A

M&A Mergers and Acquisitions Debt Finance

Cooley’s 2023 Cross-Border M&A Year in Review: Navigating Choppy Waters into a More Buoyant 2024

Cooley M&A

JANUARY 25, 2024

The higher interest rates escalated borrowing expenses, making mega-deals (deals valued at $5 billion or more) significantly more expensive, due to their heavy reliance on debt financing, and impacted valuation multiples with higher discount rates. The aggressive rate hikes contributed to the decline in M&A activity in 2023.

M&A

M&A Mergers and Acquisitions Investment Government

Cooley’s 2022 Tech M&A Year in Review

Cooley M&A

JANUARY 25, 2023

billion, a 36% decrease from 2021’s record high of $1.1 As was the case in 2021, software deals remained the strongest performer within the tech sector, representing approximately 90% of tech M&A deals. billion acquisition of ForgeRock entirely with equity commitments that could be reduced prior to closing with debt proceeds.

M&A

M&A Mergers and Acquisitions Private Equity Mergers

Cooley’s 2024 Tech M&A Year in Review:We’re So Back (It’s So Over)

Cooley M&A

FEBRUARY 3, 2025

There were 19 take-privates of US-listed tech targets by private equity sponsors in 2024, up from 16 in 2023, and even approaching the 21 take-privates announced in each of the boom years of 2021 and 2022. [3] billion acquisition of Smartsheet. billion take-private of R1 RCM by TowerBrook and CD&R.

M&A

M&A Mergers and Acquisitions Private Equity Acquisitions

Investment Banking Today

Medical Debt

How the Growth of Private Credit is Impacting Private Equity

Trending Sources

Earnouts: Bridging the Gap in Price Negotiation

Comprehensive Guide to M&A Due Diligence in Today’s Turbulent Economic Environment

Cooley’s 2022 Life Sciences M&A Year in Review

A Rollercoaster Ride for Software Markets

Have Your Cake, and Closing Too: Invoking Prevention Doctrine, Delaware Chancery Court Grants Seller’s Request for Specific Performance in COVID-Related M&A Dispute

2024 Insurance M&A Market Update: Robust But Complicated

Leaders in Trading 2023: Meet the nominees for… Outstanding Post-Trade Services Provider

Schemes of Arrangement: Dodgy Plots or Effective Ways to Purchase UK Companies?

Insurance Brokerage M&A Report, H2 2024

Diving Into Delaware’s Enforcement of Specific Performance in M&A Transactions

Cooley’s 2023 Cross-Border M&A Year in Review: Navigating Choppy Waters into a More Buoyant 2024

Cooley’s 2022 Tech M&A Year in Review

Cooley’s 2024 Tech M&A Year in Review:We’re So Back (It’s So Over)

Stay Connected